Genbank accession No. AF010238 (Nov. 24, 2000).* |
Latif et al (Science 1993, vol. 28, pp. 1317-1320, abstract only).* |
GenBank accession No. U22431 (1995).* |
Nature (London), vol. 339, No. 6733, pp. 271-275, (1999). Maxwell et al., “The Tumour Suppressor Protein VHL Targets Hypoxia-Inducible Factors for Oxygen-dependent Proteolysis.” |
Science, vol. 284, No. 5413, pp. 455-461, (1999). Stebbins et al., Structure of the VHL ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function. |
Kidney International, vol. 51, No. 2, pp. 575-578, (1997). Levy et al., “Regulation of Vascular Endothelial Growth Factor by Hypoxia and its Modulation by the von Hippel-Lindau Tumor Suppressor Gene.” |
J. Bio. Chem., vol. 272, No. 17, pp. 11205-11214, (1997). Pugh et al., “Activation of Hypoxia-Inducible Factor-1 Definition of Regulatory Domains within the Alpha Subunit.” |
J. Bio. Chem., vol. 272, No. 31, pp. 19253-19260 (1997). Jiang et al., “Transactivation and Inhibitory Domains of Hypoxia-Inducible Factor 1-alpha.” |
J. Bio. Chem., vol. 274, No. 10, pp. 6519-6525 (1999). Kallio et al., “Regulation of the Hypoxia-Inducible Transcription Factor 1α by the ubiquitin-proteasome Pathway.” |
Proc. Natl. Acad. Sci., vol. 94, pp. 8104-8109, (1997). Maxwell et al. “Hypoxia-inducible Factor-1 Modulates Gene Expression in Solid Tumors and Influences Both Angiogenesis and Tumor Growth.” |